PEGylated recombinant human hyaluronidase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PEGylated recombinant human hyaluronidase, covering 2020-07-14 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma [Phase 3]